Copanlisib plus rituximab (C+R) reduces disease progression or death in patients with relapsed indolent non-Hodgkin lymphoma (iNHL), according to a study presented during Week 1 of the annual meeting of the American Association ...
Apr 14, 2021
0
2
Results of the phase III Inter-B-NHL-ritux 2010 clinical trial reported today in the New England Journal of Medicine show 95 percent three-year survival for pediatric patients with advanced B-cell non-Hodgkin lymphoma treated ...
Jun 4, 2020
0
0
(HealthDay)—Prurigo nodularis (PN) is associated with mental health disorders, systemic illnesses, and HIV infection, according to a study published online Aug. 15 in the Journal of Investigative Dermatology.
Aug 23, 2019
0
11
To reduce your risk of cancer, you know you should quit smoking, exercise regularly, wear sunscreen, and take advantage of screening tests. New research suggests another item might be added to this list: Choose organic foods ...
Oct 22, 2018
0
658
People who inherit genetic changes which alter the function of their immune system are at increased risk of developing Hodgkin lymphoma, a major new study reports.
Dec 1, 2017
0
354
Hodgkin lymphoma survivors have more severe coronary artery disease 20 years after chest irradiation, according to research presented today at ICNC 2017.
May 8, 2017
0
0
The age at which cancer survivors were diagnosed for cancer may help determine their risk of death from heart disease, according to new research in the American Heart Association's journal Circulation.
Nov 7, 2016
0
0
Using a statistical method developed at St. Jude Children's Research Hospital, investigators found that survivors of pediatric Hodgkin lymphoma not only have more cardiovascular conditions than adults who did not have cancer ...
Jul 25, 2016
0
97
Early diagnosis, targeted therapeutics, and more personalized multimodal treatments have boosted survival rates of patients with cancer and have led to a large and rapidly increasing number of cancer survivors. This is particularly ...
Nov 18, 2015
0
4
Survivors of Hodgkin lymphoma appear to be at higher risk for cardiovascular diseases and both physicians and patients need to be aware of this increased risk, according to an article published online by JAMA Internal Medicine.
Apr 27, 2015
0
6
